Newborn affected by noxious substances transmitted via placenta or breast milk

Newborn affected by maternal anesthesia and analgesia in pregnancy, labor and delivery

P04.0

Newborn affected by other maternal medication

P04.1

Newborn affected by maternal antineoplastic chemotherapy

P04.11

Newborn affected by maternal cytotoxic drugs

P04.12

Newborn affected by maternal use of anticonvulsants

P04.13

Newborn affected by maternal use of opiates

P04.14

Newborn affected by maternal use of antidepressants

P04.15

Newborn affected by maternal use of amphetamines

P04.16

Newborn affected by maternal use of sedative-hypnotics

P04.17

Newborn affected by other maternal medication

P04.18

Newborn affected by maternal use of unspecified medication

P04.19

Newborn affected by maternal use of anxiolytics

P04.1A

Newborn affected by maternal use of tobacco

P04.2

Newborn affected by maternal use of alcohol

P04.3

Newborn affected by maternal use of drugs of addiction

P04.4

Newborn affected by maternal use of unspecified drugs of addiction

P04.40

Newborn affected by maternal use of cocaine

P04.41

Newborn affected by maternal use of hallucinogens

P04.42

Newborn affected by maternal use of other drugs of addiction

P04.49

Newborn affected by maternal use of nutritional chemical substances

P04.5

Newborn affected by maternal exposure to environmental chemical substances

P04.6

Newborn affected by other maternal noxious substances

P04.8

Newborn affected by maternal use of cannabis

P04.81

Newborn affected by other maternal noxious substances

P04.89

Newborn affected by maternal noxious substance, unspecified

P04.9